Natural History of Hepatitis C in Patients With Normal Liver Tests
Sponsor
University of California, San Francisco (Other)
Overall Status
Completed
CT.gov ID
NCT00187473
Collaborator
(none)
92
259
Study Details
Study Description
Brief Summary
The Major goals of this project was to assess the natural history of disease in chronic hepatitis C patients with normal ALT and to determine the virologic and host factors associated with disease severity.
| Condition or Disease | Intervention/Treatment | Phase |
|---|---|---|
|
Study Design
Study Type:
Observational
Actual Enrollment
:
92 participants
Observational Model:
Cohort
Time Perspective:
Other
Official Title:
Determinants of Disease Severity in Patients With Chronic Hepatitis C and Normal Serum Aminotransferases (Normal Liver Tests)
Actual Study Start Date
:
Jun 1, 2000
Actual Primary Completion Date
:
Dec 31, 2021
Actual Study Completion Date
:
Dec 31, 2021
Outcome Measures
Primary Outcome Measures
- ALT [March 2015]
Eligibility Criteria
Criteria
Ages Eligible for Study:
18 Years
and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
-
Patients with chronic hepatitis C and persistently normal liver enzymes
-
able to give consent
Exclusion Criteria:
-
decompensated liver disease
-
any prior antiviral or immunosuppressive therapy
-
other liver disease besides hepatitis C
Contacts and Locations
Locations
No locations specified.Sponsors and Collaborators
- University of California, San Francisco
Investigators
- Principal Investigator: Mandana Khalili, MD, University of California, San Francisco
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.Responsible Party:
University of California, San Francisco
ClinicalTrials.gov Identifier:
NCT00187473
Other Study ID Numbers:
- H10102-17633
First Posted:
Sep 16, 2005
Last Update Posted:
Apr 27, 2022
Last Verified:
Apr 1, 2022
Keywords provided by University of California, San Francisco
Additional relevant MeSH terms: